Category: Uncategorized

DISTANCE LEARNING: here is a completely charming and old-world perspective that will make you smile and wish the universe had more of these kind souls in it. http://www.simontaylorsblog.com/2013/02/10/the-death-of-distance/ View in LinkedIn

MAKING IP MORE ACCESSIBLE by methods like rating systems is a worthy cause. IP is a critical driver of investment in innovation. Out of the approximately 7 M patents in the USPTO, I estimate (from experience not empirically) that less than 15% are actually licensed and used to develop products. This is a goldmine for new product ideas, even when you discard the one third that are either impractical or just academic. http://lnkd.in/zGnei8 View in LinkedIn

EUROPE'S INNOVATIVE MEDICINE INITIATIVE with 1 billion € from the private sector, and 1 billion € from the public sector, is one of the largest healthcare discovery initiatives. This remarkably innovative enterprise is the ultimate public-private venture, and aimed at getting small innovative companies to discover new uses from abandoned Pharma drug libraries. Remarkable by any standards, an act of real leadership in the face of the Crisis. http://www.worldpharmanews.com/development/2341-196-million-pan-european-drug-discovery-platform-launched View in LinkedIn

NEW EARLY STAGE BIOTECH FUND. View in LinkedIn

THE NEED FOR A COLD CHAIN FOR DEVELOPING COUNTRIES VACCINES is a significant obstacle for healthcare initiatives. It also contributes about 80% of the cost. Remember that Next Generation DNA VACCINES do not require a cold chain, and can be delivered nasally, making delivery significantly less challenging. View in LinkedIn

CHINA'S INTEREST IN BIOTECH DRUGS IS SPURRING INVESTMENTS. Capable of implementing very long-term and well-funded initiatives, China is becoming an influential player in world investment markets. The JPM breakout session a couple of years ago featured Chinese Pharma companies talking about brand drugs. This was a significant sea change, because it meant that they would enforce patent protection. Watch this space. http://lnkd.in/Swa-RQ View in LinkedIn

"CAN YOU MAKE GUMBOOTS FOR FROGS OUT OF THIS?" my old chemistry professor used to say. This memorably zany question stuck front and central un my brain thereafter. It was a repurposing question before we were using the word repurposing. Taffy's great article highlights the benefits of repurposing beyond pharmaceuticals. http://lnkd.in/umerTY View in LinkedIn

THE BEIJING GENOMICS INSTITUTE, with a whopping 4,000 staff and a massive 1.58 B USD funding, is a phenomenal undertaking. Symbolic of the future power of DNA sequencing and its applications, it gives a boost to biotech worldwide. The time for harnessing international collaborations with such giants is now. http://lnkd.in/WK9r-g View in LinkedIn

0 View in LinkedIn

WESTERN PHARMA's R&D MODEL is clearly broken, so just ranking highly for throwing capital at a research organization is not impressive. Better to see that capital divided into numerous outsourced financings with small innovative companies, who are infinitely mire productive and imaginative. http://m.timesofindia.com/business/india-business/Indian-companies-top-global-charts-for-investment-in-RD/articleshow/18099909.cms View in LinkedIn